Georgia Capital Shareholder and Market Opportunity Overview

AGGREGATED EBITDA DEVELOPMENT ACROSS PRIVATE PORTFOLIO AGGREGATED EBITDA UP 25.3% Y-O-Y IN 1Q21 AND UP 45.9% FROM 1019 LTM 1021 aggregated EBITDA up 6.3% y-o-y GEL MILLION 53 +45.9% 61 8 +25.3% 77 716 289 9 25 +6.3% 307 40 40 39 GEORGIA CAPITAL 57 53 62 255 228 (4) 1Q19 1Q20 1Q21 LTM 1Q20 LTM 1Q21 ■Large portfolio companies I Investment stage portfolio companies Other portfolio companies Total EBITDA Georgia Capital PLC | General note: Revenues from Medical Centre University Clinic (HTMC) are excluded for the presentation purposes. 34

View entire presentation